Role of 5-alpha-reductase inhibitors in active surveillance of patients with low-risk prostate cancer

被引:0
|
作者
Chiang, Andrew Szehsun [1 ]
Loblaw, D. Andrew [1 ]
Jethava, Vibhuti [1 ]
Sethukavalan, Perakaa [1 ]
Zhang, Liying [1 ]
Vesprini, Danny [1 ]
Mamedov, Alexandre [1 ]
Nam, Robert [1 ]
Klotz, Laurence [1 ]
机构
[1] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
关键词
D O I
10.1200/jco.2012.30.5_suppl.14
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
14
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Utility of 5-alpha-reductase inhibitors in active surveillance for favourable risk prostate cancer
    Chiang, Andrew S.
    Loblaw, D. Andrew
    Jethava, Vibhuti
    Sethukavalan, Perakaa
    Zhang, Liying
    Vesprini, Danny
    Mamedov, Alexandre
    Nam, Robert
    Klotz, Laurence
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (11-12): : 450 - 453
  • [2] 5-ALPHA-REDUCTASE INHIBITORS IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Dai, Charles
    Ganesan, Vishnu
    Zabell, Joseph
    Nyame, Yaw
    Hettel, Daniel
    Almassi, Nima
    Greene, Daniel
    Haywood, Samuel
    Reichard, Chad
    Zampini, Anna
    Crane, Alice
    Arora, Hans
    El-Shafei, Ahmed
    Stein, Robert
    Fareed, Khaled
    Gong, Michael
    Jones, J. Stephen
    Stephenson, Andrew
    Klein, Eric
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E229 - E229
  • [3] The role of 5-alpha-reductase inhibitors in active surveillance
    Margel, David
    Fleshner, Neil
    [J]. CURRENT OPINION IN UROLOGY, 2012, 22 (03) : 243 - 246
  • [4] Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
    Augustin, Herbert
    Mayerhofer, Katrin
    Seles, Maximilian
    Pummer, Karl
    [J]. UROLOGIA INTERNATIONALIS, 2015, 95 (02) : 125 - 131
  • [7] The use of 5-alpha-reductase inhibitors for the prevention of prostate cancer
    Yu, Eun-mi
    El-Ayass, Walid
    Aragon-Ching, Jeanny B.
    [J]. CANCER BIOLOGY & THERAPY, 2010, 10 (01) : 11 - 12
  • [8] Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer
    Finelli, A.
    Komisarenko, M.
    Martin, L. J.
    Timilshina, N.
    Jain, K.
    Morris, J.
    Zlotta, A.
    Kulkarni, G.
    Perlis, N.
    van der Kwast, T.
    Evans, A.
    Ghai, S.
    Fleshner, N.
    Alibhai, S. M. H.
    Hamilton, R. J.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (01) : 69 - 76
  • [9] Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer
    A. Finelli
    M. Komisarenko
    L. J. Martin
    N. Timilshina
    K. Jain
    J. Morris
    A. Zlotta
    G. Kulkarni
    N. Perlis
    T. van der Kwast
    A. Evans
    S. Ghai
    N. Fleshner
    S. M. H. Alibhai
    R. J. Hamilton
    [J]. Prostate Cancer and Prostatic Diseases, 2021, 24 : 69 - 76
  • [10] 5-alpha reductase inhibitors diminish the rate of progression in men with low risk prostate cancer on active surveillance
    Finelli, A.
    Trottier, G.
    Lawrentschuk, N.
    Sowerby, R. J.
    Zlotta, A. R.
    Radomski, L.
    Timilshina, N.
    Evans, A.
    Van der Kwast, T. H.
    Toi, A.
    Jewett, M. A. S.
    Trachtenberg, J.
    Fleshner, N. E.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E1092 - U273